Clinical Trial Update: Vorinostat Combined With Gemtuzumab Ozogamicin, Idarubicin and Cytarabine in Acute Myeloid Leukemia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the combination of vorinostat with gemtuzumab ozogamicin, idarubicin, and cytarabine in patients with acute myeloid leuke…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Gemtuzumab ozogamicin (gemtuzumab ozogamicin)
• Idarubicin (idarubicin)
• Vorinostat (vorinostat)

Snippet

Sponsor: Samsung Medical Center | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: UNKNOWN